Symbol:
Pkia
Name:
cAMP-dependent protein kinase inhibitor alpha
RGD ID:
621021
Description:
Predicted to enable cAMP-dependent protein kinase inhibitor activity and protein kinase A catalytic subunit binding activity. Predicted to be involved in negative regulation of cAMP/PKA signal transduction. Predicted to act upstream of or within negative regulation of macromolecule metabolic process; negative regulation of protein import into nucleus; and regulation of G2/M transition of mitotic cell cycle. Predicted to be active in cytoplasm and nucleus. Orthologous to human PKIA (cAMP-dependent protein kinase inhibitor alpha); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 2,3,7,8-Tetrachlorodibenzofuran; 4,4'-diaminodiphenylmethane.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
cAMP-dependent protein kinase inhibitor, muscle/brain isoform; PKI-alpha; protein kinase (cAMP-dependent, catalytic) inhibitor alpha; protein kinase inhibitor, alpha
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
PKIA (cAMP-dependent protein kinase inhibitor alpha)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Mus musculus (house mouse):
Pkia (protein kinase inhibitor, alpha)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Pkia (cAMP-dependent protein kinase inhibitor alpha)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
PKIA (cAMP-dependent protein kinase inhibitor alpha)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
PKIA (cAMP-dependent protein kinase inhibitor alpha)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Pkia (cAMP-dependent protein kinase inhibitor alpha)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
PKIA (cAMP-dependent protein kinase inhibitor alpha)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
PKIA (cAMP-dependent protein kinase inhibitor alpha)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Pkia (cAMP-dependent protein kinase inhibitor alpha)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
NRG3 (neuregulin 3)
HGNC
OMA
Alliance orthologs 3
Homo sapiens (human):
PKIA (cAMP-dependent protein kinase inhibitor alpha)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Pkia (protein kinase inhibitor, alpha)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
si:dkey-7n6.2
Alliance
DIOPT (Hieranoid|InParanoid|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
pkia
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 2 96,306,181 - 96,380,959 (-) NCBI GRCr8 mRatBN7.2 2 94,398,869 - 94,473,638 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 2 94,398,869 - 94,414,282 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 2 100,940,617 - 101,013,056 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 2 99,061,683 - 99,134,114 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 2 94,118,529 - 94,190,968 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 2 96,593,185 - 96,668,222 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 2 96,595,088 - 96,668,222 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 2 116,337,037 - 116,411,705 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 2 96,524,399 - 96,548,144 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 2 96,469,360 - 96,493,106 (-) NCBI Celera 2 89,943,091 - 90,015,481 (-) NCBI Celera Cytogenetic Map 2 q23 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Pkia Rat 1,2-dimethylhydrazine decreases expression ISO Pkia (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of PKIA mRNA CTD PMID:22206623 Pkia Rat 17beta-estradiol multiple interactions ISO PKIA (Homo sapiens) 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of PKIA mRNA CTD PMID:17404688 Pkia Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Pkia (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of PKIA mRNA CTD PMID:19770486 and PMID:19933214 Pkia Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PKIA mRNA CTD PMID:33387578 Pkia Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Pkia (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of PKIA mRNA CTD PMID:21570461 Pkia Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of PKIA mRNA CTD PMID:22298810 Pkia Rat 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 Pkia Rat 2-methylcholine affects expression ISO PKIA (Homo sapiens) 6480464 beta-methylcholine affects the expression of PKIA mRNA CTD PMID:21179406 Pkia Rat 3',5'-cyclic AMP multiple interactions ISO PKIA (Homo sapiens) 6480464 [PRKACB protein mutant form affects the susceptibility to Cyclic AMP] results in decreased stability of [PRKACB protein mutant form binds to PKIA protein] CTD PMID:29669941 Pkia Rat 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of PKIA mRNA CTD PMID:30723492 Pkia Rat 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of PKIA mRNA CTD PMID:24780913 and PMID:36843608 Pkia Rat acetamide increases expression EXP 6480464 acetamide results in increased expression of PKIA mRNA CTD PMID:31881176 Pkia Rat acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of PKIA mRNA CTD PMID:28959563 Pkia Rat afimoxifene increases expression ISO PKIA (Homo sapiens) 6480464 afimoxifene results in increased expression of PKIA mRNA CTD PMID:16849584 Pkia Rat aflatoxin B1 decreases expression ISO Pkia (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of PKIA mRNA CTD PMID:19770486 Pkia Rat aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of PKIA mRNA CTD PMID:23630614 and PMID:25378103 Pkia Rat all-trans-retinoic acid increases expression ISO PKIA (Homo sapiens) 6480464 Tretinoin results in increased expression of PKIA mRNA CTD PMID:23724009 Pkia Rat alpha-Zearalanol decreases expression EXP 6480464 Zeranol results in decreased expression of PKIA mRNA CTD PMID:35163327 Pkia Rat alpha-Zearalanol multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PKIA mRNA CTD PMID:35163327 Pkia Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PKIA mRNA CTD PMID:16483693 Pkia Rat aristolochic acid A decreases expression ISO PKIA (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of PKIA mRNA CTD PMID:33212167 Pkia Rat arsane affects methylation ISO PKIA (Homo sapiens) 6480464 Arsenic affects the methylation of PKIA gene CTD PMID:25304211 Pkia Rat arsenic atom affects methylation ISO PKIA (Homo sapiens) 6480464 Arsenic affects the methylation of PKIA gene CTD PMID:25304211 Pkia Rat arsenite(3-) decreases methylation ISO PKIA (Homo sapiens) 6480464 arsenite results in decreased methylation of PKIA promoter CTD PMID:23974009 Pkia Rat benzo[a]pyrene decreases expression ISO Pkia (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of PKIA mRNA CTD PMID:19770486 Pkia Rat benzo[a]pyrene increases expression ISO PKIA (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of PKIA mRNA CTD PMID:32234424 Pkia Rat benzo[a]pyrene increases methylation ISO PKIA (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of PKIA 5' UTR and Benzo(a)pyrene results in increased methylation of PKIA promoter CTD PMID:27901495 Pkia Rat bis(2-ethylhexyl) phthalate increases expression ISO Pkia (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of PKIA mRNA CTD PMID:28085963 Pkia Rat bisphenol A decreases expression ISO PKIA (Homo sapiens) 6480464 bisphenol A results in decreased expression of PKIA mRNA CTD PMID:22576693 Pkia Rat bisphenol A multiple interactions ISO PKIA (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of PKIA gene CTD PMID:31601247 Pkia Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PKIA mRNA CTD PMID:30816183 and PMID:32145629 Pkia Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PKIA mRNA CTD PMID:25181051 Pkia Rat bisphenol A increases methylation ISO PKIA (Homo sapiens) 6480464 bisphenol A results in increased methylation of PKIA gene CTD PMID:22576693 Pkia Rat bortezomib increases expression ISO PKIA (Homo sapiens) 6480464 Bortezomib results in increased expression of PKIA mRNA CTD PMID:20977926 Pkia Rat butanal increases expression ISO PKIA (Homo sapiens) 6480464 butyraldehyde results in increased expression of PKIA mRNA CTD PMID:26079696 Pkia Rat C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of PKIA mRNA CTD PMID:19167457 Pkia Rat cadmium dichloride decreases expression ISO PKIA (Homo sapiens) 6480464 Cadmium Chloride results in decreased expression of PKIA mRNA CTD PMID:38568856 Pkia Rat cantharidin decreases expression ISO Pkia (Mus musculus) 6480464 Cantharidin results in decreased expression of PKIA mRNA CTD PMID:36907384 Pkia Rat carbamazepine affects expression ISO PKIA (Homo sapiens) 6480464 Carbamazepine affects the expression of PKIA mRNA CTD PMID:25979313 Pkia Rat CGP 52608 multiple interactions ISO PKIA (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to PKIA gene] CTD PMID:28238834 Pkia Rat choline multiple interactions ISO Pkia (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PKIA mRNA CTD PMID:20938992 Pkia Rat chrysene increases expression ISO Pkia (Mus musculus) 6480464 chrysene results in increased expression of PKIA mRNA CTD PMID:26377693 Pkia Rat cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of PKIA mRNA CTD PMID:24386269 Pkia Rat cyclosporin A decreases expression ISO PKIA (Homo sapiens) 6480464 Cyclosporine results in decreased expression of PKIA mRNA CTD PMID:20106945 Pkia Rat cytarabine decreases expression ISO PKIA (Homo sapiens) 6480464 Cytarabine results in decreased expression of PKIA mRNA CTD PMID:21198554 Pkia Rat dexamethasone increases expression ISO Pkia (Mus musculus) 6480464 Dexamethasone results in increased expression of PKIA mRNA CTD PMID:22185406 Pkia Rat dibutyl phthalate increases expression ISO Pkia (Mus musculus) 6480464 Dibutyl Phthalate results in increased expression of PKIA mRNA CTD PMID:21266533 Pkia Rat diquat decreases expression ISO Pkia (Mus musculus) 6480464 Diquat results in decreased expression of PKIA mRNA CTD PMID:36851058 Pkia Rat dorsomorphin multiple interactions ISO PKIA (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Pkia Rat doxorubicin affects response to substance ISO PKIA (Homo sapiens) 6480464 PKIA protein affects the susceptibility to Doxorubicin CTD PMID:16217747 Pkia Rat doxorubicin decreases expression ISO PKIA (Homo sapiens) 6480464 Doxorubicin results in decreased expression of PKIA mRNA CTD PMID:29803840 Pkia Rat doxorubicin decreases expression ISO Pkia (Mus musculus) 6480464 Doxorubicin results in decreased expression of PKIA mRNA CTD PMID:25896364 Pkia Rat endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of PKIA mRNA CTD PMID:29391264 Pkia Rat ethanol affects splicing ISO Pkia (Mus musculus) 6480464 Ethanol affects the splicing of PKIA mRNA CTD PMID:30319688 Pkia Rat folic acid multiple interactions ISO Pkia (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PKIA mRNA CTD PMID:20938992 Pkia Rat folic acid decreases expression ISO Pkia (Mus musculus) 6480464 Folic Acid results in decreased expression of PKIA mRNA CTD PMID:25629700 Pkia Rat fulvestrant multiple interactions ISO PKIA (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of PKIA gene CTD PMID:31601247 Pkia Rat hydrazine decreases expression ISO Pkia (Mus musculus) 6480464 hydrazine results in decreased expression of PKIA mRNA CTD PMID:15282401 Pkia Rat hydroquinone decreases expression ISO PKIA (Homo sapiens) 6480464 hydroquinone results in decreased expression of PKIA mRNA CTD PMID:31256213 Pkia Rat L-methionine multiple interactions ISO Pkia (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PKIA mRNA CTD PMID:20938992 Pkia Rat lead(0) affects splicing ISO PKIA (Homo sapiens) 6480464 Lead affects the splicing of PKIA mRNA CTD PMID:28903495 Pkia Rat lead(0) affects expression ISO PKIA (Homo sapiens) 6480464 Lead affects the expression of PKIA mRNA CTD PMID:28903495 Pkia Rat lipopolysaccharide increases expression ISO Pkia (Mus musculus) 6480464 Lipopolysaccharides results in increased expression of PKIA mRNA CTD PMID:22185406 Pkia Rat mitomycin C affects response to substance ISO PKIA (Homo sapiens) 6480464 PKIA protein affects the susceptibility to Mitomycin CTD PMID:16217747 Pkia Rat ozone multiple interactions ISO Pkia (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PKIA mRNA CTD PMID:34911549 Pkia Rat paracetamol affects response to substance EXP 6480464 PKIA affects the susceptibility to Acetaminophen CTD PMID:24910983 Pkia Rat paracetamol increases expression ISO PKIA (Homo sapiens) 6480464 Acetaminophen results in increased expression of PKIA mRNA CTD PMID:29067470 Pkia Rat paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of PKIA mRNA CTD PMID:24910983 and PMID:33387578 Pkia Rat perfluorooctanoic acid multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PKIA mRNA CTD PMID:35163327 Pkia Rat phenobarbital affects expression ISO PKIA (Homo sapiens) 6480464 Phenobarbital affects the expression of PKIA mRNA CTD PMID:19159669 Pkia Rat progesterone multiple interactions ISO PKIA (Homo sapiens) 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of PKIA mRNA CTD PMID:17404688 Pkia Rat SB 431542 multiple interactions ISO PKIA (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Pkia Rat sevoflurane affects expression EXP 6480464 sevoflurane affects the expression of PKIA mRNA CTD PMID:15967596 Pkia Rat sodium arsenite decreases expression ISO PKIA (Homo sapiens) 6480464 sodium arsenite results in decreased expression of PKIA mRNA CTD PMID:34032870 Pkia Rat Soman decreases expression EXP 6480464 Soman results in decreased expression of PKIA mRNA CTD PMID:19281266 Pkia Rat temozolomide decreases expression ISO PKIA (Homo sapiens) 6480464 Temozolomide results in decreased expression of PKIA mRNA CTD PMID:31758290 Pkia Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of PKIA mRNA CTD PMID:23411599 and PMID:34492290 Pkia Rat titanium dioxide decreases expression ISO Pkia (Mus musculus) 6480464 titanium dioxide results in decreased expression of PKIA mRNA CTD PMID:29264374 Pkia Rat titanium dioxide decreases methylation ISO Pkia (Mus musculus) 6480464 titanium dioxide results in decreased methylation of PKIA promoter CTD PMID:35295148 Pkia Rat trichostatin A decreases expression ISO PKIA (Homo sapiens) 6480464 trichostatin A results in decreased expression of PKIA mRNA CTD PMID:26272509 Pkia Rat trichostatin A multiple interactions ISO PKIA (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PKIA mRNA CTD PMID:27188386 Pkia Rat triclosan decreases expression ISO PKIA (Homo sapiens) 6480464 Triclosan results in decreased expression of PKIA mRNA CTD PMID:30510588 Pkia Rat triphenyl phosphate affects expression ISO PKIA (Homo sapiens) 6480464 triphenyl phosphate affects the expression of PKIA mRNA CTD PMID:37042841 Pkia Rat triptonide increases expression ISO Pkia (Mus musculus) 6480464 triptonide results in increased expression of PKIA mRNA CTD PMID:33045310 Pkia Rat tunicamycin decreases expression ISO PKIA (Homo sapiens) 6480464 Tunicamycin results in decreased expression of PKIA mRNA CTD PMID:22378314 Pkia Rat valproic acid affects expression ISO Pkia (Mus musculus) 6480464 Valproic Acid affects the expression of PKIA mRNA CTD PMID:17963808 Pkia Rat valproic acid multiple interactions ISO PKIA (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKIA mRNA CTD PMID:27188386 Pkia Rat valproic acid increases expression ISO PKIA (Homo sapiens) 6480464 Valproic Acid results in increased expression of PKIA mRNA CTD PMID:24383497 more ... Pkia Rat vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of PKIA mRNA CTD PMID:19015723 Pkia Rat vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of PKIA mRNA CTD PMID:22570695 Pkia Rat zinc atom increases expression EXP 6480464 Zinc results in increased expression of PKIA mRNA CTD PMID:17074742 Pkia Rat zinc sulfate increases expression EXP 6480464 Zinc Sulfate results in increased expression of PKIA mRNA CTD PMID:17074742 Pkia Rat zinc(0) increases expression EXP 6480464 Zinc results in increased expression of PKIA mRNA CTD PMID:17074742 Pkia Rat zoledronic acid decreases expression ISO PKIA (Homo sapiens) 6480464 zoledronic acid results in decreased expression of PKIA mRNA CTD PMID:24714768
1,2-dimethylhydrazine (ISO) 17beta-estradiol (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,3,7,8-Tetrachlorodibenzofuran (EXP) 2-methylcholine (ISO) 3',5'-cyclic AMP (ISO) 4,4'-diaminodiphenylmethane (EXP) 6-propyl-2-thiouracil (EXP) acetamide (EXP) acrylamide (EXP) afimoxifene (ISO) aflatoxin B1 (EXP,ISO) all-trans-retinoic acid (ISO) alpha-Zearalanol (EXP) ammonium chloride (EXP) aristolochic acid A (ISO) arsane (ISO) arsenic atom (ISO) arsenite(3-) (ISO) benzo[a]pyrene (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (EXP,ISO) bortezomib (ISO) butanal (ISO) C60 fullerene (EXP) cadmium dichloride (ISO) cantharidin (ISO) carbamazepine (ISO) CGP 52608 (ISO) choline (ISO) chrysene (ISO) cobalt dichloride (EXP) cyclosporin A (ISO) cytarabine (ISO) dexamethasone (ISO) dibutyl phthalate (ISO) diquat (ISO) dorsomorphin (ISO) doxorubicin (ISO) endosulfan (EXP) ethanol (ISO) folic acid (ISO) fulvestrant (ISO) hydrazine (ISO) hydroquinone (ISO) L-methionine (ISO) lead(0) (ISO) lipopolysaccharide (ISO) mitomycin C (ISO) ozone (ISO) paracetamol (EXP,ISO) perfluorooctanoic acid (EXP) phenobarbital (ISO) progesterone (ISO) SB 431542 (ISO) sevoflurane (EXP) sodium arsenite (ISO) Soman (EXP) temozolomide (ISO) thioacetamide (EXP) titanium dioxide (ISO) trichostatin A (ISO) triclosan (ISO) triphenyl phosphate (ISO) triptonide (ISO) tunicamycin (ISO) valproic acid (ISO) vinclozolin (EXP) zinc atom (EXP) zinc sulfate (EXP) zinc(0) (EXP) zoledronic acid (ISO)
Pkia (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 2 96,306,181 - 96,380,959 (-) NCBI GRCr8 mRatBN7.2 2 94,398,869 - 94,473,638 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 2 94,398,869 - 94,414,282 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 2 100,940,617 - 101,013,056 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 2 99,061,683 - 99,134,114 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 2 94,118,529 - 94,190,968 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 2 96,593,185 - 96,668,222 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 2 96,595,088 - 96,668,222 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 2 116,337,037 - 116,411,705 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 2 96,524,399 - 96,548,144 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 2 96,469,360 - 96,493,106 (-) NCBI Celera 2 89,943,091 - 90,015,481 (-) NCBI Celera Cytogenetic Map 2 q23 NCBI
PKIA (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 8 78,516,340 - 78,605,267 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 8 78,516,340 - 78,605,267 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 8 79,428,575 - 79,517,502 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 8 79,590,891 - 79,678,040 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 8 79,590,890 - 79,678,040 NCBI Celera 8 75,432,064 - 75,519,215 (+) NCBI Celera Cytogenetic Map 8 q21.13 NCBI HuRef 8 74,917,776 - 75,007,029 (+) NCBI HuRef CHM1_1 8 79,480,068 - 79,569,185 (+) NCBI CHM1_1 T2T-CHM13v2.0 8 78,947,862 - 79,036,793 (+) NCBI T2T-CHM13v2.0
Pkia (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 3 7,431,695 - 7,510,426 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 3 7,431,729 - 7,510,426 (+) Ensembl GRCm39 Ensembl GRCm38 3 7,366,604 - 7,445,366 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 3 7,366,669 - 7,445,366 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 3 7,366,604 - 7,445,366 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 3 7,349,743 - 7,428,439 (+) NCBI MGSCv36 mm8 Celera 3 7,377,059 - 7,462,331 (+) NCBI Celera Cytogenetic Map 3 A1 NCBI cM Map 3 1.96 NCBI
Pkia (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955444 2,498,288 - 2,532,881 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955444 2,498,785 - 2,532,881 (-) NCBI ChiLan1.0 ChiLan1.0
PKIA (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 7 94,256,162 - 94,346,166 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 8 69,884,249 - 69,974,530 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 8 75,046,316 - 75,136,264 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 8 76,677,518 - 76,766,673 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 8 76,734,210 - 76,766,673 (+) Ensembl panpan1.1 panPan2
PKIA (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 29 26,182,842 - 26,278,838 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 29 26,182,876 - 26,275,883 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 29 26,450,611 - 26,546,350 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 29 26,297,036 - 26,393,723 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 29 26,380,080 - 26,393,714 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 29 26,346,821 - 26,442,809 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 29 26,387,943 - 26,483,713 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 29 26,739,335 - 26,835,372 (+) NCBI UU_Cfam_GSD_1.0
Pkia (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
PKIA (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 4 57,872,116 - 57,977,574 (-) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 4 57,872,114 - 57,879,184 (-) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 4 63,076,489 - 63,083,559 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
PKIA (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 8 74,017,536 - 74,102,881 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 8 74,096,037 - 74,099,441 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666039 67,132,022 - 67,217,593 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Pkia (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 205 Count of miRNA genes: 146 Interacting mature miRNAs: 165 Transcripts: ENSRNOT00000016567 Prediction methods: Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
1578777 Stresp15 Stress response QTL 15 2 0.05 blood aldosterone amount (VT:0005346) plasma aldosterone level (CMO:0000551) 2 59846005 104846005 Rat 2293671 Bss44 Bone structure and strength QTL 44 10.97 0.0001 lumbar vertebra morphology trait (VT:0010494) lumbar vertebra cortical cross-sectional area (CMO:0001690) 2 43162366 148478373 Rat 1298074 Bp164 Blood pressure QTL 164 0.003 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 42804607 202447032 Rat 1598865 Bp296 Blood pressure QTL 296 2.1 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 81018907 126018907 Rat 1354648 Bp239 Blood pressure QTL 239 0.001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 66118463 226797303 Rat 1578772 Stresp14 Stress response QTL 14 5 0.001 blood renin amount (VT:0003349) plasma renin activity level (CMO:0000116) 2 82345893 130923501 Rat 1354649 Kidm17 Kidney mass QTL 17 2.9 kidney mass (VT:0002707) calculated kidney weight (CMO:0000160) 2 81754530 227146641 Rat 2293676 Bmd19 Bone mineral density QTL 19 10.7 0.0001 femur mineral mass (VT:0010011) total volumetric bone mineral density (CMO:0001728) 2 43162366 111362592 Rat 10755499 Bp389 Blood pressure QTL 389 2.61 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 2 18960362 228801039 Rat 2293682 Bmd24 Bone mineral density QTL 24 8.9 0.0001 femur mineral mass (VT:0010011) compact volumetric bone mineral density (CMO:0001730) 2 43162366 111362592 Rat 152025242 Bw191 Body weight QTL 191 3.62 body mass (VT:0001259) 2 38573329 122609194 Rat 1598862 Glom9 Glomerulus QTL 9 3.5 kidney glomerulus morphology trait (VT:0005325) index of glomerular damage (CMO:0001135) 2 92337601 137337601 Rat 631198 Cm22 Cardiac mass QTL 22 4.3 0.0008 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 2 76539322 150540526 Rat 1598863 Cm65 Cardiac mass QTL 65 2.3 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 2 92337601 137337601 Rat 1302794 Stl27 Serum triglyceride level QTL 27 4.4 0.0001 blood triglyceride amount (VT:0002644) plasma triglyceride level (CMO:0000548) 2 25413423 143657569 Rat 61465 Bp13 Blood pressure QTL 13 3.3 blood pressure trait (VT:0000183) systolic blood pressure (CMO:0000004) 2 76539322 102785628 Rat 1581569 Uae32 Urinary albumin excretion QTL 32 0.0001 urine protein amount (VT:0005160) urine albumin excretion rate (CMO:0000757) 2 78665619 219826953 Rat 61467 Bp14 Blood pressure QTL 14 2.2 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 43154682 202446871 Rat 70174 BpQTLCluster2 Blood pressure QTL cluster 2 4.24 arterial blood pressure trait (VT:2000000) absolute change in mean arterial blood pressure (CMO:0000533) 2 40067944 102785628 Rat 1358901 Cm38 Cardiac mass QTL 38 2 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 2 25413423 157142209 Rat 1331760 Bp206 Blood pressure QTL 206 3.62454 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 2 56043031 202447032 Rat 2300165 Bmd49 Bone mineral density QTL 49 4.8 0.0001 lumbar vertebra mineral mass (VT:0010511) bone mineral density (CMO:0001226) 2 88862519 133862519 Rat 1358899 Kidm23 Kidney mass QTL 23 3.88 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 2 25413423 157142209 Rat 1358908 Bw49 Body weight QTL 49 3.36 body mass (VT:0001259) body weight (CMO:0000012) 2 25413652 157142078 Rat 5684990 Bmd82 Bone mineral density QTL 82 2.8 tibia mineral mass (VT:1000283) bone mineral content (CMO:0001554) 2 59324377 103795077 Rat 2300170 Bmd45 Bone mineral density QTL 45 12.1 0.0001 lumbar vertebra mineral mass (VT:0010511) volumetric bone mineral density (CMO:0001553) 2 88862519 133862519 Rat 1358910 Kidm27 Kidney mass QTL 27 5.77 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 2 25413423 157142209 Rat 61355 Bp36 Blood pressure QTL 36 2.9 blood pressure trait (VT:0000183) systolic blood pressure (CMO:0000004) 2 5873687 102844969 Rat 1358911 Kidm28 Kidney mass QTL 28 5.42 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 2 25413423 157142209 Rat 1358904 Cm39 Cardiac mass QTL 39 2.26 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 2 25413423 157142209 Rat 7411551 Bw131 Body weight QTL 131 29.6 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 2 67942638 112942638 Rat 1358887 Bw50 Body weight QTL 50 2.39 body mass (VT:0001259) body weight (CMO:0000012) 2 25413652 157142078 Rat 1298080 Bp163 Blood pressure QTL 163 0.02 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 66118275 202447032 Rat 8662832 Vetf7 Vascular elastic tissue fragility QTL 7 3.5 aorta elastin amount (VT:0003905) aorta wall extracellular elastin dry weight to aorta wall dry weight ratio (CMO:0002002) 2 81689826 221035911 Rat 1298085 Bp165 Blood pressure QTL 165 0.0006 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 42804607 202447032 Rat 2290453 Scl55 Serum cholesterol level QTL 55 2.83 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 2 26917817 136917119 Rat 2299162 Iddm32 Insulin dependent diabetes mellitus QTL 32 2.36 blood glucose amount (VT:0000188) age at onset/diagnosis of type 1 diabetes mellitus (CMO:0001140) 2 78665616 143657569 Rat 1358894 Kidm24 Kidney mass QTL 24 4.03 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 2 25413423 157142209 Rat 2300185 Bmd46 Bone mineral density QTL 46 8.4 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 2 88862519 133862519 Rat 724534 Uae6 Urinary albumin excretion QTL 6 10 urine albumin amount (VT:0002871) urine albumin level (CMO:0000130) 2 78665619 249053267 Rat 61374 Edpm2 Estrogen-dependent pituitary mass QTL 2 4.42 0.86 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 2 76539322 202447032 Rat 631500 Bp99 Blood pressure QTL 99 2.5 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 59324719 102755241 Rat 61392 Bp6 Blood pressure QTL 6 7 arterial blood pressure trait (VT:2000000) pulse pressure (CMO:0000292) 2 80270434 125270434 Rat 1358917 Cm42 Cardiac mass QTL 42 2.82 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 2 25413423 203928301 Rat 5684996 Bmd85 Bone mineral density QTL 85 4.7 0.024 tibia mineral mass (VT:1000283) bone mineral density (CMO:0001226) 2 59324377 103795077 Rat 1358913 Cm41 Cardiac mass QTL 41 2.73 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 2 25413423 203928301 Rat 2293835 Kiddil5 Kidney dilation QTL 5 3.8 kidney pelvis morphology trait (VT:0004194) hydronephrosis severity score (CMO:0001208) 2 42804607 157142209 Rat 1558653 Prcr1 Prostate cancer resistance QTL 1 5 prostate integrity trait (VT:0010571) area of ventral prostate occupied by tumorous lesions to total ventral prostate area ratio (CMO:0000899) 2 72532993 157142209 Rat 1354622 Kidm16 Kidney mass QTL 16 3 kidney mass (VT:0002707) left kidney wet weight (CMO:0000083) 2 81754530 222436696 Rat 631266 Bp132 Blood pressure QTL 132 0.0005 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 46123260 202447032 Rat 7207808 Bmd89 Bone mineral density QTL 89 4.1 femur strength trait (VT:0010010) femoral neck ultimate force (CMO:0001703) 2 88862519 133862519 Rat 1558648 Smcn1 Smooth muscle cell number QTL 1 0.039 blood vessel smooth muscle cell quantity (VT:0010525) aorta smooth muscle cell count per unit vessel length (CMO:0001646) 2 59134147 127460910 Rat 2293843 Kiddil6 Kidney dilation QTL 6 3.1 kidney pelvis morphology trait (VT:0004194) hydronephrosis severity score (CMO:0001208) 2 42804607 182042367 Rat 2306903 Bp336 Blood pressure QTL 336 0.01 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 64366971 109366971 Rat 152025206 Hrtrt23 Heart rate QTL 23 5.98 heart pumping trait (VT:2000009) 2 28484589 169504100 Rat 1354605 Rf48 Renal function QTL 48 2.9 blood creatinine amount (VT:0005328) plasma creatinine level (CMO:0000537) 2 74786664 206665859 Rat 152025204 Hrtrt22 Heart rate QTL 22 5.6 heart pumping trait (VT:2000009) 2 28484589 169504100 Rat 1354601 Slep1 Serum leptin concentration QTL 1 5.39 blood leptin amount (VT:0005667) serum leptin level (CMO:0000780) 2 43171017 184114403 Rat 61438 Cia7 Collagen induced arthritis QTL 7 4.6 0.0001 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 2 59324377 141596857 Rat 1354603 Bp243 Blood pressure QTL 243 3.9 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 2 26917817 127469484 Rat
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000016567 ⟹ ENSRNOP00000016567
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 2 94,398,869 - 94,414,282 (-) Ensembl Rnor_6.0 Ensembl 2 96,595,088 - 96,668,222 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000112828 ⟹ ENSRNOP00000077194
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 2 94,398,869 - 94,414,282 (-) Ensembl
RefSeq Acc Id:
NM_053772 ⟹ NP_446224
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 2 96,308,084 - 96,380,915 (-) NCBI mRatBN7.2 2 94,400,772 - 94,473,599 (-) NCBI Rnor_6.0 2 96,595,088 - 96,668,222 (-) NCBI Rnor_5.0 2 116,337,037 - 116,411,705 (-) NCBI RGSC_v3.4 2 96,524,399 - 96,548,144 (-) RGD Celera 2 89,943,091 - 90,015,481 (-) NCBI
Sequence:
CTGCAGCTGCAGGTGGGGCGGGGGCCTTGCGAGCCCAGAGAGCCCAGCACACGCGGCCGGGCGGGCGGGACTGCTGCCGGGGGCAGCCGGGACGCGCCTCTCCATCCCGAAGCTTCCTGAATACCAAG ACCTGATGTGTCCAAGAGGCCGTTTCTAGTAGAAACCTGAAGAACATCTCTAAGAAAGAATAATCCAATGAATTGAGAACAAGAAGGTTTCTAATCAGGTACTGCCACTGTGCTCTCTCTCTCTTTCA CCTTTGGTTCCATTGGAACAGGATCCCAGATCTCAAACCCTTTCCTACCATCAGAGACTGCCCCTGTAAAGAGCACTGTTCCTCAGGCTAGAGTCCCTGCTATGTGGATATTTGTTAGCAATGACTGA TGTGGAAACTACGTATGCAGATTTTATTGCCTCAGGAAGAACAGGTAGAAGAAATGCAATACATGATATCTTGGTTTCCTCTGCAAGTGGCAACAGCAATGAATTAGCCTTGAAATTAGCAGGTCTTG ATATTAACAAGACAGAAGGTGAAGATGATGGACAGAGAAGCTCCACAGAACAAAGTGGCGAAGCCCAGGGAGAAGCAGCCAAGTCTGAAAGCTAACACTCCATTCTGACGGTCATCAACACCTGACGA TGTGGCGAATCTCCTGGCATTGCTCGGATGAATTTGCGGCCATGGGTGAAACGGAGGAGAAGAAAATGGCCGTGATGAATGGCAAGAAGCCGTTGGTTGCCATGTCACGAATGGGGGCAGAGCCTGTG TCTGCACACAGCCTTTCCCCCACCTCTCTCATTAGCAATGGTTGAAATCACCTGGCCTGTGCTTGGATATCATTTTTGTATGGGTCCTTTCACTTGACCGTTTAATGAAATGCTTGTAGAGAGTAGCA CTGACCTAGCTGATGATTCCTGTAGCATCTGGCCCCTCATGATGTCAGAGGATTTAATTGTGTCTAATTGAAAAGGGTTGGTTGAACCCCAGAGTTTCCATATCTCTGGCTGGAGTATTGGCTCACCA AAAGAACCATCCAGAGAGCACAGTTAGCATTATGTCTCTGTGTGTGAGTGCTGTGTTATTTACACCGTTTTGTATCGTACAGTATACCTGCTCAGCACTGCCCTTTGATTGCTTATGTAAAACAAAAT GAAGTACATTGACTGTGAATTTTTATACCACTCATTTTTTTAAAGGGCTGCCTTTTTAATTTCCCATAGTGTTGTGGTGTGCACGGGGCAGAACCTGCTTTTGTAAAACACGACTTTCCTCTTGATGA CTTCTGAGGGTTATATCCAACAGACTCACTGAGCCCCCCTTTGCTTTATTATACAGGCATGTGGAAATATCCATTAATGTGAATATTGCCTGAGTTCAGTTTTAGTATCTACACAGACCAGTGTTCTG TCTGTCAATATTGATTTTATTTCCAAGTAAGTTCTTTCAGCTAACAACTTCATTTTTCATGATTAAGAATTTTTAAGAATTGACAAGGTAGACAAAGAAAGTCAGATAATGCAAAGGACTGGAAACAT TGTGTTCTGTGGATCACTTTGGTCACATTGATGGGTACCACTGTTTAACTTGGGAGGACAGCTTGTGAAGGAAGTGTTCTCCTCAAAGCCTGTGGGCACCCGTCTATAAAGGAAAGTCCTTGGGATGT GTTCTCCCATGTCCCCTCTCAGCCCTTTCATAATGTTATTATGCACTTTTTAATGTTTGTAAAATTTTACTAATAATTTGTGTGAATTGCTTTGAGATATAATAATTATCACCCAACCACACTTTTAC TGACGCTGTTGATGGACTATGCTGTGTTTTGACATCACGATTCTTGTATGGGGAATGTCTGTGGCCTATGTAACCCCCTCTGGTCAGTATTATGAAGCCAACTATCTTTGGTAATAAATAAGGATCCA GTTAGATGCCCAGGGTTAATCTGGGGCATCTTATGGGCAAATAACAGATGA
hide sequence
RefSeq Acc Id:
XM_006232153 ⟹ XP_006232215
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 2 96,306,181 - 96,321,295 (-) NCBI mRatBN7.2 2 94,398,869 - 94,413,983 (-) NCBI Rnor_6.0 2 96,593,185 - 96,608,706 (-) NCBI Rnor_5.0 2 116,337,037 - 116,411,705 (-) NCBI
Sequence:
TGTATTAGGTTGATTGGTATCCTTCACAGAATTAATAAATACTTATATTTGACCAGTTCTTTCA TTTTTCACATGGTAAATGTTAGCAGATTTGTTCCACGTAAATGAAAGCTCTTTAGAGTTTTTGACCACCGTTTGTAACACAGGGAAGTCTTAGAAAACACCGATGTATATTGAATACTGAGTGCACAG GAAACTACACGTGATTTCATTATTTTAACATTTGCGAATTGTTGCCACTGAATTTGGGAGTGGAGCAAGACACATTTTTTCTGCTTCTGACATTTAAATCTCATTTTAAAAACTGCACTGTTCACGCC AAAGTCCTCATTGTATGCTGGAGGCCGTCTCTCCATCCTCCTTCCAAGCCTGCGACTCCCATTTCATGTGTCCCATTTACAGAAGTAAAATTAGCATGTTCTTCAGTCACCATTTGGCTCATGACTCA ATGTCACTATAAAAATCATCTTAGCAGCTTCGTAGGCTCAGTTTCTTCGAGGATACCCCGATGTGGAAAGCTTCAGTATAAGCTAGGAAGCTCCCTGCTATGTGGATATTTGTTAGCAATGACTGATG TGGAAACTACGTATGCAGATTTTATTGCCTCAGGAAGAACAGGTAGAAGAAATGCAATACATGATATCTTGGTTTCCTCTGCAAGTGGCAACAGCAATGAATTAGCCTTGAAATTAGCAGGTCTTGAT ATTAACAAGACAGAAGGTGAAGATGATGGACAGAGAAGCTCCACAGAACAAAGTGGCGAAGCCCAGGGAGAAGCAGCCAAGTCTGAAAGCTAACACTCCATTCTGACGGTCATCAACACCTGACGATG TGGCGAATCTCCTGGCATTGCTCGGATGAATTTGCGGCCATGGGTGAAACGGAGGAGAAGAAAATGGCCGTGATGAATGGCAAGAAGCCGTTGGTTGCCATGTCACGAATGGGGGCAGAGCCTGTGTC TGCACACAGCCTTTCCCCCACCTCTCTCATTAGCAATGGTTGAAATCACCTGGCCTGTGCTTGGATATCATTTTTGTATGGGTCCTTTCACTTGACCGTTTAATGAAATGCTTGTAGAGAGTAGCACT GACCTAGCTGATGATTCCTGTAGCATCTGGCCCCTCATGATGTCAGAGGATTTAATTGTGTCTAATTGAAAAGGGTTGGTTGAACCCCAGAGTTTCCATATCTCTGGCTGGAGTATTGGCTCACCAAA AGAACCATCCAGAGAGCACAGTTAGCATTATGTCTCTGTGTGTGAGTGCTGTGTTATTTACACCGTTTTGTATCGTACAGTATACCTGCTCAGCACTGCCCTTTGATTGCTTATGTAAAACAAAATGA AGTACATTGACTGTGAATTTTTATACCACTCATTTTTTTAAAGGGCTGCCTTTTTAATTTCCCATAGTGTTGTGGTGTGCACGGGGCAGAACCTGCTTTTGTAAAACACGACTTTCCTCTTGATGACT TCTGAGGGTTATATCCAACAGACTCACTGAGCCCCCCTTTGCTTTATTATACAGGCATGTGGAAATATCCATTAATGTGAATATTGCCTGAGTTCAGTTTTAGTATCTACACAGACCAGTGTTCTGTC TGTCAATATTGATTTTATTTCCAAGTAAGTTCTTTCAGCTAACAACTTCATTTTTCATGATTAAGAATTTTTAAGAATTGACAAGGTAGACAAAGAAAGTCAGATAATGCAAAGGACTGGAAACATTG TGTTCTGTGGATCACTTTGGTCACATTGATGGGTACCACTGTTTAACTTGGGAGGACAGCTTGTGAAGGAAGTGTTCTCCTCAAAGCCTGTGGGCACCCGTCTATAAAGGAAAGTCCTTGGGATGTGT TCTCCCATGTCCCCTCTCAGCCCTTTCATAATGTTATTATGCACTTTTTAATGTTTGTAAAATTTTACTAATAATTTGTGTGAATTGCTTTGAGATATAATAATTATCACCCAACCACACTTTTACTG ACGCTGTTGATGGACTATGCTGTGTTTTGACATCACGATTCTTGTATGGGGAATGTCTGTGGCCTATGTAACCCCCTCTGGTCAGTATTATGAAGCCAACTATCTTTGGTAATAAATAAGGATCCAGT TAGATGCCCAGGGTTAATCTGGGGCATCTTATGGGCAAATAACAGATGAAAGAAGGCCTTCGCAACAGAAGAGCCCCTAAATGTCCTAGAGTGCAGGCATAGCTGCAGTTCCAGGTTAAGTAGGGAGC AGTGATTCAGCAGGCAGACTATGGGTGTGGTAGGAACTCAACCTGAGTCTGTAGTCACAGACAAAGTAGACAGGAAGTCTGCCCATATCTTCCTATAGTGCATTCATTACTGACTGGGAATACATGAA TCTCATTAGTCTCCAACTGGAAGTTTTCCAGAAAAACAAGCAATGTATGTCTTTCTGGATATAAAACAGTAAATACATTCAATATGAGAGGCCTTGCTTTGATCTAACTCATTGGAGGCTAGCTAAAA TTGAAACAAATCTACCTATTGGTAGAATCAAAGCTGTGAACCTGTGGCTTATTTGAGACAACCTCTGATAATCTATTAACAATATCCAACAGTTTCAATGTCCTTGTTGAACTATCCTGGTACCTTTC TCGTGAATAGGAAGTTCATTCTTAAAGTTGTAGAATTCCAAATTGGTTTTACGTGCATTTTGTAAAGTGTTGAACCAGTGCTGAGTCCATCCCTGTGTGATATACTATTACTAATGCATGTGGTGCCA TGCTTGTCTTCAAATATAGAAGTAGTGCTAAATGGGGAAGTCGTATGGAGCTTCTGATTTCCTTTGACCTCTTACTACTACTTTGTTTCCTGTATTCAATCCCAGAGGGATTCTCTGGCTGGGAAGGG AAAAAAAATCAACATTCTAAATTTTCCACATTGCATAAATTTTGATTGGCAACATATATAGACTCTCCTGATTTTCATTTAATACCTGTTATTTACAAGTAAATAATAATAATAGGGAAGTGATCTGT AAAGACAAATGGAAGAGTAGGTAGCCCGAGCAAAGGGTGTTATTTAACTATCCCAACGAAGTCACTTCAGGACACTTTCTTTTCACCTTTTGAAACACACCATTTAGACTTTAATCTTGCTCCCCTTT CACACATTAGGAAGTAAACACAAATAACAACAAGTTTTTGCAAGATTAAAAAACTAATTTGAGCATATATGTATTTATCGACAGAATTGTGAATCCACAGGTTATAAAATTAAAGCTAATTATACAGT ATGTTTCTCTGTATGGAAAACTAGAAATACACTCATTCAGCTTGCATGTTACAGAGAAGGAGAATAAGTTTCAAAAATGGACTGGCCTTTCTTGCATTTGTACACATGTCTTTGGGGCAAAGACAGAT GTGGCAAAGCCTACTTTTGTGGCTTTCCACTTAAATATTCAATTATACCTTATTTTGAGAGTTTACTTCTGGTATGTAAACTGTAAATTTACATGCTATGTTTATGCTACATATGTGAACAAATATTC TTGCTTTTCATTTAGTTACCTAGAAACACAGAATTTTTCATTTTTAACACATTAACAATGAATGAGAAGCTGTTGAATTTGTTGAGTTTAACTTTTTTTTTAACTGAGAATATTTTATGTCAGTACAT ATTCATCCTGAGCTCACAGAAATGCTTTCTGCCCTGTAACAGAAATCACGATCTTCATTTTTCAGGGAATACTAACATAGCCCGTCGATAGCCTACCACTGAGTCTTCCGCACACATGACAGCATGGA ACCAATGTAGATTTTAAAAATGACATCTTTATCCTTCTCAGAGGAATAAGAAAAAATGTAACTGTTGGGCAGCAAGCTTCTGAATGAGACCTGCCGTAGTAAGGGGAAAAGTATAGTCGTTAAATTAA ACCAAGAAAGGATCCATAATGATGTCTTAGAGGCCCGGAACTGTTCCTTCATTGACTAGCGACAGCCTGGGAAGTCATCTGTGAGCTTCTATGACTTTTGTATTTAGCAATGTTGCATGCTCCAATAA TTGATATTAAAAGCAACACTTGTTTTCTGAAA
hide sequence
RefSeq Acc Id:
XM_006232155 ⟹ XP_006232217
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 2 96,306,181 - 96,380,959 (-) NCBI mRatBN7.2 2 94,398,869 - 94,473,638 (-) NCBI Rnor_6.0 2 96,593,185 - 96,668,196 (-) NCBI Rnor_5.0 2 116,337,037 - 116,411,705 (-) NCBI
Sequence:
TTGCGAGCCCAGAGAGCCCAGCACACGCGGCCGGGCGGGCGGGACTGCTGCCGGGGGCAGCCGG GACGCGCCTCTCCATCCCGAAGCTTCCTGAATACCAAGACCTGATGTGTCCAAGAGGCCGTTTCTAGTAGAAACCTGAAGAACATCTCTAAGAAAGAATAATCCAATGAATTGAGAACAAGAAGGTTT CTAATCAGTCCCTGCTATGTGGATATTTGTTAGCAATGACTGATGTGGAAACTACGTATGCAGATTTTATTGCCTCAGGAAGAACAGGTAGAAGAAATGCAATACATGATATCTTGGTTTCCTCTGCA AGTGGCAACAGCAATGAATTAGCCTTGAAATTAGCAGGTCTTGATATTAACAAGACAGAAGGTGAAGATGATGGACAGAGAAGCTCCACAGAACAAAGTGGCGAAGCCCAGGGAGAAGCAGCCAAGTC TGAAAGCTAACACTCCATTCTGACGGTCATCAACACCTGACGATGTGGCGAATCTCCTGGCATTGCTCGGATGAATTTGCGGCCATGGGTGAAACGGAGGAGAAGAAAATGGCCGTGATGAATGGCAA GAAGCCGTTGGTTGCCATGTCACGAATGGGGGCAGAGCCTGTGTCTGCACACAGCCTTTCCCCCACCTCTCTCATTAGCAATGGTTGAAATCACCTGGCCTGTGCTTGGATATCATTTTTGTATGGGT CCTTTCACTTGACCGTTTAATGAAATGCTTGTAGAGAGTAGCACTGACCTAGCTGATGATTCCTGTAGCATCTGGCCCCTCATGATGTCAGAGGATTTAATTGTGTCTAATTGAAAAGGGTTGGTTGA ACCCCAGAGTTTCCATATCTCTGGCTGGAGTATTGGCTCACCAAAAGAACCATCCAGAGAGCACAGTTAGCATTATGTCTCTGTGTGTGAGTGCTGTGTTATTTACACCGTTTTGTATCGTACAGTAT ACCTGCTCAGCACTGCCCTTTGATTGCTTATGTAAAACAAAATGAAGTACATTGACTGTGAATTTTTATACCACTCATTTTTTTAAAGGGCTGCCTTTTTAATTTCCCATAGTGTTGTGGTGTGCACG GGGCAGAACCTGCTTTTGTAAAACACGACTTTCCTCTTGATGACTTCTGAGGGTTATATCCAACAGACTCACTGAGCCCCCCTTTGCTTTATTATACAGGCATGTGGAAATATCCATTAATGTGAATA TTGCCTGAGTTCAGTTTTAGTATCTACACAGACCAGTGTTCTGTCTGTCAATATTGATTTTATTTCCAAGTAAGTTCTTTCAGCTAACAACTTCATTTTTCATGATTAAGAATTTTTAAGAATTGACA AGGTAGACAAAGAAAGTCAGATAATGCAAAGGACTGGAAACATTGTGTTCTGTGGATCACTTTGGTCACATTGATGGGTACCACTGTTTAACTTGGGAGGACAGCTTGTGAAGGAAGTGTTCTCCTCA AAGCCTGTGGGCACCCGTCTATAAAGGAAAGTCCTTGGGATGTGTTCTCCCATGTCCCCTCTCAGCCCTTTCATAATGTTATTATGCACTTTTTAATGTTTGTAAAATTTTACTAATAATTTGTGTGA ATTGCTTTGAGATATAATAATTATCACCCAACCACACTTTTACTGACGCTGTTGATGGACTATGCTGTGTTTTGACATCACGATTCTTGTATGGGGAATGTCTGTGGCCTATGTAACCCCCTCTGGTC AGTATTATGAAGCCAACTATCTTTGGTAATAAATAAGGATCCAGTTAGATGCCCAGGGTTAATCTGGGGCATCTTATGGGCAAATAACAGATGAAAGAAGGCCTTCGCAACAGAAGAGCCCCTAAATG TCCTAGAGTGCAGGCATAGCTGCAGTTCCAGGTTAAGTAGGGAGCAGTGATTCAGCAGGCAGACTATGGGTGTGGTAGGAACTCAACCTGAGTCTGTAGTCACAGACAAAGTAGACAGGAAGTCTGCC CATATCTTCCTATAGTGCATTCATTACTGACTGGGAATACATGAATCTCATTAGTCTCCAACTGGAAGTTTTCCAGAAAAACAAGCAATGTATGTCTTTCTGGATATAAAACAGTAAATACATTCAAT ATGAGAGGCCTTGCTTTGATCTAACTCATTGGAGGCTAGCTAAAATTGAAACAAATCTACCTATTGGTAGAATCAAAGCTGTGAACCTGTGGCTTATTTGAGACAACCTCTGATAATCTATTAACAAT ATCCAACAGTTTCAATGTCCTTGTTGAACTATCCTGGTACCTTTCTCGTGAATAGGAAGTTCATTCTTAAAGTTGTAGAATTCCAAATTGGTTTTACGTGCATTTTGTAAAGTGTTGAACCAGTGCTG AGTCCATCCCTGTGTGATATACTATTACTAATGCATGTGGTGCCATGCTTGTCTTCAAATATAGAAGTAGTGCTAAATGGGGAAGTCGTATGGAGCTTCTGATTTCCTTTGACCTCTTACTACTACTT TGTTTCCTGTATTCAATCCCAGAGGGATTCTCTGGCTGGGAAGGGAAAAAAAATCAACATTCTAAATTTTCCACATTGCATAAATTTTGATTGGCAACATATATAGACTCTCCTGATTTTCATTTAAT ACCTGTTATTTACAAGTAAATAATAATAATAGGGAAGTGATCTGTAAAGACAAATGGAAGAGTAGGTAGCCCGAGCAAAGGGTGTTATTTAACTATCCCAACGAAGTCACTTCAGGACACTTTCTTTT CACCTTTTGAAACACACCATTTAGACTTTAATCTTGCTCCCCTTTCACACATTAGGAAGTAAACACAAATAACAACAAGTTTTTGCAAGATTAAAAAACTAATTTGAGCATATATGTATTTATCGACA GAATTGTGAATCCACAGGTTATAAAATTAAAGCTAATTATACAGTATGTTTCTCTGTATGGAAAACTAGAAATACACTCATTCAGCTTGCATGTTACAGAGAAGGAGAATAAGTTTCAAAAATGGACT GGCCTTTCTTGCATTTGTACACATGTCTTTGGGGCAAAGACAGATGTGGCAAAGCCTACTTTTGTGGCTTTCCACTTAAATATTCAATTATACCTTATTTTGAGAGTTTACTTCTGGTATGTAAACTG TAAATTTACATGCTATGTTTATGCTACATATGTGAACAAATATTCTTGCTTTTCATTTAGTTACCTAGAAACACAGAATTTTTCATTTTTAACACATTAACAATGAATGAGAAGCTGTTGAATTTGTT GAGTTTAACTTTTTTTTTAACTGAGAATATTTTATGTCAGTACATATTCATCCTGAGCTCACAGAAATGCTTTCTGCCCTGTAACAGAAATCACGATCTTCATTTTTCAGGGAATACTAACATAGCCC GTCGATAGCCTACCACTGAGTCTTCCGCACACATGACAGCATGGAACCAATGTAGATTTTAAAAATGACATCTTTATCCTTCTCAGAGGAATAAGAAAAAATGTAACTGTTGGGCAGCAAGCTTCTGA ATGAGACCTGCCGTAGTAAGGGGAAAAGTATAGTCGTTAAATTAAACCAAGAAAGGATCCATAATGATGTCTTAGAGGCCCGGAACTGTTCCTTCATTGACTAGCGACAGCCTGGGAAGTCATCTGTG AGCTTCTATGACTTTTGTATTTAGCAATGTTGCATGCTCCAATAATTGATATTAAAAGCAACACTTGTTTTCTGAAA
hide sequence
RefSeq Acc Id:
XM_008760857 ⟹ XP_008759079
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 2 96,306,181 - 96,321,210 (-) NCBI mRatBN7.2 2 94,398,869 - 94,413,898 (-) NCBI Rnor_6.0 2 96,593,185 - 96,608,708 (-) NCBI
Sequence:
TATGTATTAGGTTGATTGGTATCCTTCACAGAATTAATAAATACTTATATTTGACCAGTTCTTTCATTTTTCACATGGTAAATGTTAGCAGATTTGTTCCACGTAAATGAAAGCTCTTTAGAGTTTTT GACCACCGTTTGTAACACAGGGAAGTCTTAGAAAACACCGATGTATATTGAATACTGAGTGCACAGGAAACTACACGTGATTTCATTATTTTAACATTTGCGAATTGTTGCCACTGAATTTGGGAGTG GAGCAAGACACATTTTTTCTGCTTCTGACATTTAAATCTCATTTTAAAAACTGCACTGTTCACGCCAAAGTCCTCATTGTATGCTGGAGGCCGTCTCTCCATCCTCCTTCCAAGCCTGCGACTCCCAT TTCATGTGTCCCATTTACAGAAGTAAAATTAGCATGTTCTTCAGTCACCATTTGGCTCATGACTCAATGTCACTATAAAAATCATCTTAGCAGCTTCGTAGGCTCAGTTTCTTCGAGGATACCCCGAT GTGGAAAGCTTCAGTATAAGCTAGGAAGCCTTTCTTCTTCCAGATACACAGTGTCCTCTAGAATTCCCTATCACAAAGCAGGCTGGTCCACTAGCTTTTTGGCATGGAACAAGGAAGACAGCAAACAT CTAAGGACAATTAAATATGTTTCCCTGCTATGTGGATATTTGTTAGCAATGACTGATGTGGAAACTACGTATGCAGATTTTATTGCCTCAGGAAGAACAGGTAGAAGAAATGCAATACATGATATCTT GGTTTCCTCTGCAAGTGGCAACAGCAATGAATTAGCCTTGAAATTAGCAGGTCTTGATATTAACAAGACAGAAGGTGAAGATGATGGACAGAGAAGCTCCACAGAACAAAGTGGCGAAGCCCAGGGAG AAGCAGCCAAGTCTGAAAGCTAACACTCCATTCTGACGGTCATCAACACCTGACGATGTGGCGAATCTCCTGGCATTGCTCGGATGAATTTGCGGCCATGGGTGAAACGGAGGAGAAGAAAATGGCCG TGATGAATGGCAAGAAGCCGTTGGTTGCCATGTCACGAATGGGGGCAGAGCCTGTGTCTGCACACAGCCTTTCCCCCACCTCTCTCATTAGCAATGGTTGAAATCACCTGGCCTGTGCTTGGATATCA TTTTTGTATGGGTCCTTTCACTTGACCGTTTAATGAAATGCTTGTAGAGAGTAGCACTGACCTAGCTGATGATTCCTGTAGCATCTGGCCCCTCATGATGTCAGAGGATTTAATTGTGTCTAATTGAA AAGGGTTGGTTGAACCCCAGAGTTTCCATATCTCTGGCTGGAGTATTGGCTCACCAAAAGAACCATCCAGAGAGCACAGTTAGCATTATGTCTCTGTGTGTGAGTGCTGTGTTATTTACACCGTTTTG TATCGTACAGTATACCTGCTCAGCACTGCCCTTTGATTGCTTATGTAAAACAAAATGAAGTACATTGACTGTGAATTTTTATACCACTCATTTTTTTAAAGGGCTGCCTTTTTAATTTCCCATAGTGT TGTGGTGTGCACGGGGCAGAACCTGCTTTTGTAAAACACGACTTTCCTCTTGATGACTTCTGAGGGTTATATCCAACAGACTCACTGAGCCCCCCTTTGCTTTATTATACAGGCATGTGGAAATATCC ATTAATGTGAATATTGCCTGAGTTCAGTTTTAGTATCTACACAGACCAGTGTTCTGTCTGTCAATATTGATTTTATTTCCAAGTAAGTTCTTTCAGCTAACAACTTCATTTTTCATGATTAAGAATTT TTAAGAATTGACAAGGTAGACAAAGAAAGTCAGATAATGCAAAGGACTGGAAACATTGTGTTCTGTGGATCACTTTGGTCACATTGATGGGTACCACTGTTTAACTTGGGAGGACAGCTTGTGAAGGA AGTGTTCTCCTCAAAGCCTGTGGGCACCCGTCTATAAAGGAAAGTCCTTGGGATGTGTTCTCCCATGTCCCCTCTCAGCCCTTTCATAATGTTATTATGCACTTTTTAATGTTTGTAAAATTTTACTA ATAATTTGTGTGAATTGCTTTGAGATATAATAATTATCACCCAACCACACTTTTACTGACGCTGTTGATGGACTATGCTGTGTTTTGACATCACGATTCTTGTATGGGGAATGTCTGTGGCCTATGTA ACCCCCTCTGGTCAGTATTATGAAGCCAACTATCTTTGGTAATAAATAAGGATCCAGTTAGATGCCCAGGGTTAATCTGGGGCATCTTATGGGCAAATAACAGATGAAAGAAGGCCTTCGCAACAGAA GAGCCCCTAAATGTCCTAGAGTGCAGGCATAGCTGCAGTTCCAGGTTAAGTAGGGAGCAGTGATTCAGCAGGCAGACTATGGGTGTGGTAGGAACTCAACCTGAGTCTGTAGTCACAGACAAAGTAGA CAGGAAGTCTGCCCATATCTTCCTATAGTGCATTCATTACTGACTGGGAATACATGAATCTCATTAGTCTCCAACTGGAAGTTTTCCAGAAAAACAAGCAATGTATGTCTTTCTGGATATAAAACAGT AAATACATTCAATATGAGAGGCCTTGCTTTGATCTAACTCATTGGAGGCTAGCTAAAATTGAAACAAATCTACCTATTGGTAGAATCAAAGCTGTGAACCTGTGGCTTATTTGAGACAACCTCTGATA ATCTATTAACAATATCCAACAGTTTCAATGTCCTTGTTGAACTATCCTGGTACCTTTCTCGTGAATAGGAAGTTCATTCTTAAAGTTGTAGAATTCCAAATTGGTTTTACGTGCATTTTGTAAAGTGT TGAACCAGTGCTGAGTCCATCCCTGTGTGATATACTATTACTAATGCATGTGGTGCCATGCTTGTCTTCAAATATAGAAGTAGTGCTAAATGGGGAAGTCGTATGGAGCTTCTGATTTCCTTTGACCT CTTACTACTACTTTGTTTCCTGTATTCAATCCCAGAGGGATTCTCTGGCTGGGAAGGGAAAAAAAATCAACATTCTAAATTTTCCACATTGCATAAATTTTGATTGGCAACATATATAGACTCTCCTG ATTTTCATTTAATACCTGTTATTTACAAGTAAATAATAATAATAGGGAAGTGATCTGTAAAGACAAATGGAAGAGTAGGTAGCCCGAGCAAAGGGTGTTATTTAACTATCCCAACGAAGTCACTTCAG GACACTTTCTTTTCACCTTTTGAAACACACCATTTAGACTTTAATCTTGCTCCCCTTTCACACATTAGGAAGTAAACACAAATAACAACAAGTTTTTGCAAGATTAAAAAACTAATTTGAGCATATAT GTATTTATCGACAGAATTGTGAATCCACAGGTTATAAAATTAAAGCTAATTATACAGTATGTTTCTCTGTATGGAAAACTAGAAATACACTCATTCAGCTTGCATGTTACAGAGAAGGAGAATAAGTT TCAAAAATGGACTGGCCTTTCTTGCATTTGTACACATGTCTTTGGGGCAAAGACAGATGTGGCAAAGCCTACTTTTGTGGCTTTCCACTTAAATATTCAATTATACCTTATTTTGAGAGTTTACTTCT GGTATGTAAACTGTAAATTTACATGCTATGTTTATGCTACATATGTGAACAAATATTCTTGCTTTTCATTTAGTTACCTAGAAACACAGAATTTTTCATTTTTAACACATTAACAATGAATGAGAAGC TGTTGAATTTGTTGAGTTTAACTTTTTTTTTAACTGAGAATATTTTATGTCAGTACATATTCATCCTGAGCTCACAGAAATGCTTTCTGCCCTGTAACAGAAATCACGATCTTCATTTTTCAGGGAAT ACTAACATAGCCCGTCGATAGCCTACCACTGAGTCTTCCGCACACATGACAGCATGGAACCAATGTAGATTTTAAAAATGACATCTTTATCCTTCTCAGAGGAATAAGAAAAAATGTAACTGTTGGGC AGCAAGCTTCTGAATGAGACCTGCCGTAGTAAGGGGAAAAGTATAGTCGTTAAATTAAACCAAGAAAGGATCCATAATGATGTCTTAGAGGCCCGGAACTGTTCCTTCATTGACTAGCGACAGCCTGG GAAGTCATCTGTGAGCTTCTATGACTTTTGTATTTAGCAATGTTGCATGCTCCAATAATTGATATTAAAAGCAACACTTGTTTTCTGAAA
hide sequence
RefSeq Acc Id:
NP_446224 ⟸ NM_053772
- UniProtKB:
P63249 (UniProtKB/Swiss-Prot), A6IH81 (UniProtKB/TrEMBL)
- Sequence:
MTDVETTYADFIASGRTGRRNAIHDILVSSASGNSNELALKLAGLDINKTEGEDDGQRSSTEQSGEAQGEAAKSES
hide sequence
RefSeq Acc Id:
XP_006232217 ⟸ XM_006232155
- Peptide Label:
isoform X1
- UniProtKB:
P63249 (UniProtKB/Swiss-Prot), A6IH81 (UniProtKB/TrEMBL)
- Sequence:
MTDVETTYADFIASGRTGRRNAIHDILVSSASGNSNELALKLAGLDINKTEGEDDGQRSSTEQSGEAQGEAAKSES
hide sequence
RefSeq Acc Id:
XP_006232215 ⟸ XM_006232153
- Peptide Label:
isoform X2
- UniProtKB:
A0A8L2Q830 (UniProtKB/TrEMBL)
- Sequence:
MTQCHYKNHLSSFVGSVSSRIPRCGKLQYKLGSSLLCGYLLAMTDVETTYADFIASGRTGRRNAIHDILVSSASGNSNELALKLAGLDINKTEGEDDGQRSSTEQSGEAQGEAAKSES
hide sequence
RefSeq Acc Id:
XP_008759079 ⟸ XM_008760857
- Peptide Label:
isoform X1
- UniProtKB:
P63249 (UniProtKB/Swiss-Prot), A6IH81 (UniProtKB/TrEMBL)
- Sequence:
MTQCHYKNHLSSFVGSVSSRIPRCGKLQYKLGSLSSSRYTVSSRIPYHKAGWSTSFLAWNKEDSKHLRTIKYVSLLCGYLLAMTDVETTYADFIASGRTGRRNAIHDILVSSASGNSNELALKLAGLD INKTEGEDDGQRSSTEQSGEAQGEAAKSES
hide sequence
Ensembl Acc Id:
ENSRNOP00000016567 ⟸ ENSRNOT00000016567
Ensembl Acc Id:
ENSRNOP00000077194 ⟸ ENSRNOT00000112828
RGD ID: 13691246
Promoter ID: EPDNEW_R1770
Type: multiple initiation site
Name: Pkia_1
Description: cAMP-dependent protein kinase inhibitor alpha
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 2 96,668,230 - 96,668,290 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2017-01-03
Pkia
cAMP-dependent protein kinase inhibitor alpha
Pkia
protein kinase (cAMP-dependent, catalytic) inhibitor alpha
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2008-09-09
Pkia
protein kinase (cAMP-dependent, catalytic) inhibitor alpha
Pkia
protein kinase inhibitor, alpha
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2005-01-20
Pkia
protein kinase inhibitor, alpha
Symbol and Name status set to approved
1299863
APPROVED
2002-08-07
Pkia
protein kinase inhibitor, alpha
Symbol and Name status set to provisional
70820
PROVISIONAL